Does CAPLACIZUMAB-YHDP Cause Epistaxis? 123 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 123 reports of Epistaxis have been filed in association with CAPLACIZUMAB-YHDP. This represents 8.8% of all adverse event reports for CAPLACIZUMAB-YHDP.
123
Reports of Epistaxis with CAPLACIZUMAB-YHDP
8.8%
of all CAPLACIZUMAB-YHDP reports
2
Deaths
29
Hospitalizations
How Dangerous Is Epistaxis From CAPLACIZUMAB-YHDP?
Of the 123 reports, 2 (1.6%) resulted in death, 29 (23.6%) required hospitalization, and 2 (1.6%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB-YHDP. However, 123 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB-YHDP Cause?
Product use in unapproved indication (465)
Adamts13 activity decreased (136)
Off label use (133)
Platelet count decreased (126)
Fatigue (110)
Contusion (86)
Injection site pain (74)
Headache (71)
Adamts13 activity abnormal (63)
Injection site bruising (63)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which CAPLACIZUMAB-YHDP Alternatives Have Lower Epistaxis Risk?
CAPLACIZUMAB-YHDP vs CAPMATINIB
CAPLACIZUMAB-YHDP vs CAPREOMYCIN
CAPLACIZUMAB-YHDP vs CAPSAICIN
CAPLACIZUMAB-YHDP vs CAPTOPRIL
CAPLACIZUMAB-YHDP vs CARBAMAZEPINE